Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and
 Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Inclusion Criteria:

 -  Male and female 11-25 years old healthy subjects;

 -  who had received the primary immunization with a vaccine containing DT or Tdap
 antigens and a T, Td, or Tdap booster injection at least 5 years prior to study entry

 Exclusion Criteria:

 -  previous ascertained or suspected disease caused by N. meningitidis

 -  previously been immunized with a meningococcal vaccine or vaccine containing
 meningococcal antigen(s)

 -  serious acute, chronic or progressive disease

 -  history of any anaphylaxis, serious vaccine reactions, or allergy to any vaccine
 component

 -  known or suspected impairment/alteration of immune function, either congenital or
 acquired